Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Return on Sales (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Return on Sales for 3 consecutive years, with 1.39% as the latest value for Q1 2026.

  • Quarterly Return on Sales rose 5.0% to 1.39% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 1.62% through Jan 2026, down 144.0% year-over-year, with the annual reading at 1.76% for FY2025, 109.0% down from the prior year.
  • Return on Sales for Q1 2026 was 1.39% at Kestra Medical Technologies, up from 1.45% in the prior quarter.
  • The five-year high for Return on Sales was 5.28% in Q2 2024, with the low at 2.61% in Q1 2024.
  • Average Return on Sales over 3 years is 0.94%, with a median of 1.44% recorded in 2025.
  • Peak annual rise in Return on Sales hit 117bps in 2025, while the deepest fall reached -777bps in 2025.
  • Over 3 years, Return on Sales stood at 1.4% in 2024, then decreased by -4bps to 1.45% in 2025, then increased by 4bps to 1.39% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1.39%, 1.45%, and 1.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.